A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

  1. Tabernero, J.
  2. Climent, M.A.
  3. Lluch, A.
  4. Albanell, J.
  5. Vermorken, J.B.
  6. Barnadas, A.
  7. Antón, A.
  8. Laurent, C.
  9. Mayordomo, J.I.
  10. Estaun, N.
  11. Losa, I.
  12. Guillem, V.
  13. Garcia-Conde, J.
  14. Tisaire, J.L.
  15. Baselga, J.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534

Argitalpen urtea: 2004

Alea: 15

Zenbakia: 9

Orrialdeak: 1358-1365

Mota: Artikulua

DOI: 10.1093/ANNONC/MDH349 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus